References
- Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614–24
- Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000;123:1703–9
- Lipton RB, Stewart WF. Acute migraine therapy: do doctors know what migraine patients want from therapy? Headache 1999;39(Suppl 2):S20–S26
- Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000;20:554–60
- MacGregor EA, Brandes J, Eikerman A. Migraine prevalence and treatment patterns: the Global Migraine and Zolmitriptan Evaluation Survey. Headache 2003;43:19–26
- Cady RK, Sheftell F, Lipton RB, et al. Effects of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000;22:1035–48
- Winner P, Mannix LK, Putnam DG, et al. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 2003;78:1214–22
- Salonen R, Scott A. Triptans: do they differ? Curr Pain Headache Rep 2002;6:133–9
- Volans GN. Migraine and drug absorption. Clin Pharmacokinet 1978; 3:313–8
- Sramek JJ, Hussey EK, Clements B, et al. Oral sumatriptan pharmacokinetics in the migraine state. Clin Drug Invest 1999;17:137–44
- Zomig® (zolmitriptan) Tablets and Zomig®-ZMT (zolmitriptan) orally disintegrating tablets. Complete Prescribing Information. Wilmington, Delaware, AstraZeneca, 2002
- Maxalt® (rizatriptan benzoate) Tablets and Maxalt-MLT® (rizatriptan benzoate) orally disintegrating tablets. Complete Prescribing Information. Whitehouse Station, New Jersey, Merck & Co., Inc., October 2001
- Kaniecki RG. Mixing sumatriptan: a prospective study of stratified care using multiple formulations. Headache 2001;41:862–6
- Gruffydd-Jones K, Hood CA, Price DB. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice. Cephalalgia 1998;17:31–6
- Dahlöf CG, Saiers JA. Sumatriptan injection and tablets in clinical practice: results of a survey of 707 migraineurs. Headache 1998;38: 756–63
- Schuirmann DJ. A comparison of the two one-sided tests procedures and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15:657–80
- Carpay H, Schoenen J, Ahmad F, et al. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation in the acute treatment of migraine. Clin Ther [submitted]
- Savani N, Loftus J, Boswell D. A randomized double-blind, placebo controlled, parallel group evaluation of sumatriptan 50 mg and 100 mg tablets administered during the mild pain phase of a menstrually associated migraine attack. Cephalalgia 2002;22: 606
- Nett R, Landy S, Shackelford S, et al. Pain-free efficacy after treatment with sumatriptan in the mild-pain phase of menstrually associated migraine. Obstet Gynecol 2003;102: 835–842